Theranostics Health and Grace Bio-Labs Strike Licensing Agreement for Novel TheraLin® Tissue Fixative

Theranostics Health, Inc. and Grace Bio-Labs of have entered into a Product Licensing Agreement for the manufacture and market distribution of Theranostic’s novel tissue preservative, TheraLin®. Under the terms of the agreement, Grace Bio-Labs will be the commercial manufacturer and distributor for the patented (US Patent 8,460,859) TheraLin® fixative with the objective of accelerating the utilization of this novel reagent for advancement of cellular and protein analysis.

Select here for product and ordering information on the TheraLin® Tissue Fixative